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Background: Inflammatory bowel disease (IBD) is now a global disease with incidence 
increasing throughout Asia.
Aim: To determine the incidence of IBD among South Asians and Chinese people residing 
in Ontario, Canada’s most populous province.
Methods: All incident cases of IBD in children (1994–2015) and adults (1999–2015) were 
identified from population-based health administrative data. We classified South Asian and 
Chinese ethnicity using immigration records and surnames. We determined standardized 
incidence of IBD and adjusted incidence rate ratio (aIRR) in South Asians and Chinese 
compared to the general population.
Results: Among 16,230,638 people living in Ontario, standardized incidence of IBD per 
100,000 person-years was 24.7 (95% CI 24.4–25.0), compared with 14.6 (95% CI 13.7–15.5) 
in 982,472 South Asians and with 5.4 (95% CI 4.8–5.9) in 764,397 Chinese. The risk of IBD in 
South Asians was comparable to the general population after adjusting for immigrant status 
and confounders (aIRR 1.03, 95% CI 0.96–1.10). South Asians had a lower risk of Crohn’s 
disease (CD) (aIRR 0.66, 95% CI 0.60–0.77), but a higher risk of ulcerative colitis (UC) (aIRR 
1.47, 95% CI 1.34–1.61). Chinese people had much lower rates of IBD (aIRR 0.24, 95% CI 
0.20–0.28), CD (aIRR 0.21, 95% CI 0.17–0.26), and UC (aIRR 0.28, 95% CI 0.23–0.25).
Conclusion: Canadians of South Asian ethnicity had a similarly high risk of developing 
IBD compared to other Canadians, and a higher risk of developing UC, a finding distinct 
from the Chinese population. Our findings indicate the importance of genetic and environ-
mental risk factors in people of Asian origin who live in the Western world.
Keywords: inflammatory bowel disease, ulcerative colitis, Crohn’s disease, incidence, 
ethnicity, epidemiology, South Asian, Chinese
Introduction
Inflammatory bowel disease (IBD) is characterized by chronic inflammation of the 
bowel and comprised of two major sub-types, Crohn’s disease (CD) and ulcerative 
colitis (UC).1 Whereas incidence of IBD is stabilizing in the Western World, it is 
rapidly increasing in newly industrialized countries.2 Canada has among the highest 
rates in the world, and prevalence is projected to rise from 0.7% in 2018 to 1% in 2030.3 
Ontario, Canada’s most populous province, has a highly diverse population, with 
visible minorities representing 29% of residents.4,5 Previous population-based studies 
from Ontario have demonstrated lower rates of IBD among immigrants from South and 
East Asia relative to non-immigrants, but rates among Canadian-born children of South 
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Asian immigrants were comparable to the children of non- 
immigrants.6 However, this study evaluated only immi-
grants, and not the influence of ethnicity in people who 
were not immigrants. To understand the role of environmen-
tal risk factors in the pathophysiology of IBD, it is important 
to understand the role of ethnicity in IBD epidemiology. In 
this population-based study, we described differences in the 
incidence of IBD in people of South Asian and Chinese 
ethnicity compared to other residents of Ontario.
Methods
Study Design, Setting and Study 
Population
We conducted a cohort study using the population-based 
health administrative data for Ontario, Canada (population 
14.4 million). We included all residents of Ontario registered 
for universal healthcare (>99% of the population) from 
fiscal year (FY) 1991 to 2018 (ie, April 1, 1991 to 
March 31, 2019). We excluded individuals with missing 
date of birth or missing valid ICES unique encrypted identi-
fication number (IKN), or those who left Ontario and then 
returned during the study period (due to incomplete adminis-
trative data). We excluded those with missing data for both 
exposure (ethnicity) and independent variables (confounders). 
Ontario residents were followed forward within the databases 
to determine whether they were diagnosed with IBD before 
April 1, 2019. This study was approved by the research ethics 
boards of the London School of Hygiene and Tropical 
Medicine (21620/RR/18073) and the Children’s Hospital of 
Eastern Ontario (19/08PE).
Data Sources
Ontario health administrative data is held at ICES, an inde-
pendent, non-profit research institute funded by an annual 
grant from the Ontario Ministry of Health (MOH) and the 
Ministry of Long-Term Care (MLTC). The datasets were 
linked deterministically using unique encoded identifiers 
(IKN) and analyzed at ICES. We identified all individuals 
from the Registered Persons Database (RPDB), which con-
tains information on all legal residents of Ontario registered 
for universal health care under the Ontario Health Insurance 
Plan (OHIP). RPBD also contains information including 
date of birth, location of residence (postal codes), sex and 
mean neighbourhood income quintile.
We linked three databases to characterize the South Asian 
and Chinese populations, and other Ontario residents defined 
as “general” (Figure 1). The ETHNIC database assigns eth-
nicity based on surnames.7 South Asian surnames are largely 
of Hindu, Sikh, Bhutan and Sri Lankan origin, and surnames 
of Christian and Muslim origin were excluded because of 
commonality with other ethnic groups. The ETHNIC data-
base has a positive predictive value (PPV) of 89.3% and 
Figure 1 Flow chart illustrating the study population cohort.
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sensitivity of 50.4% to identify South Asian individuals, and 
PPV of 91.9% and sensitivity of 80.2% to identify people of 
Chinese origin. In addition, to address possible misclassifica-
tion by the ETHNIC database, we linked immigration data 
from Immigration, Refugees and Citizenship Canada 
(IRCC)’s Permanent Residents Database8 and defined ethni-
city based on region of birth. The Ontario portion of IRCC 
data includes all immigrants arriving to Ontario after 
January 1, 1985 (people who immigrated prior to 1985 are 
misclassified as non-immigrants). As per World Bank region 
classification,9 individuals were labelled as South Asian if 
they were born in India, Pakistan, Nepal, Bangladesh, Bhutan 
or Sri Lanka. Individuals were labelled as Chinese if born in 
China, Hong Kong or Taiwan. The Canadian-born children 
of immigrant mothers were identified by linking female 
immigrants to the MOMBABY database. MOMBABY 
links maternal and new-born records of hospital births from 
1988 onward.10,11
We used the Ontario Crohn’s and Colitis Cohort 
(OCCC) to identify all incident cases of IBD, and to 
distinguish CD from UC.12,13 OCCC is a complete cohort 
of IBD patients living in Ontario from 1991 onwards. 
Validated lookback periods without health-care contacts 
for IBD were required to distinguish incident from pre-
valent cases (except for people born after April 1, 1991); 3 
years for paediatric-onset IBD and 8 years for adult- or 
elderly-onset IBD. Therefore, the paediatric incident 
cohort started April 1, 1994; the adult/elderly incident 
cases starting April 1, 1999. The algorithm to identify 
children with IBD (aged 6mo to <18 years) was found to 
have a sensitivity of 89.6–91.1%, specificity >99.9%, PPV 
of 59.2–76.0% and negative predictive value (NPV) 
>99.9%.12 In adults (aged 18 to <65 years) a sensitivity 
of 76.8–92.3%, specificity of 96.2–99.1%, PPV of 81.4% 
and NPV of 95.0%.13 The algorithm in seniors (>65 years) 
had a sensitivity of 52.2–53.7%, specificity of 98.8– 
99.3%, PPV of 76.3%, and NPV of 98.0%.13 IBD incident 
patients were further stratified as CD, UC or IBD type 
unclassifiable using a validated algorithm.12,13
Exposure Ascertainment
We identified two ethnic groups using the above- 
mentioned databases, South Asian and Chinese, and the 
remaining population defined as the “general” cohort 
served as the comparative reference population. If ethni-
city determined by immigration data differed from the 
ETHNIC database, ethnicity was assigned using country 
of birth from immigration data (Figure 1). We assessed the 
degree of concordance in assigning ethnicity between the 
ETHNIC database and IRCC immigration data. The IRCC 
and ETHNIC databases were highly concordant among 
Chinese individuals (93.5% concordance), but less concor-
dant among South Asians (37.7% concordance) 
(Supplementary Table 1).
Outcome Ascertainment
The outcome of interest was the incident diagnosis of IBD, 
identified using the OCCC with the validated algorithms 
described above.
Independent Variables (Confounders)
Multivariable models adjusted for the following a priori 
determined independent variables, identified as possible 
confounders using clinical knowledge and previous 
research: immigration status,12 sex, neighbourhood income 
quintile at cohort entry14 and Rurality Index of Ontario 
(RIO) at the time of cohort entry.15 RIO is an ordinal 
variable measures the degree of rurality and consists of 
three broad components, measure of community popula-
tion and density, measure of travel to nearest basic referral 
centre, and measure of travel time to nearest advanced 
centre.16 The RIO is a normalised scale ranging from 0 
to 100, with a score of 0 being the least rural.
Statistical Analysis
Standardized incidence was calculated per 100,000 person 
years (PYs) of follow-up, with 95% confidence intervals 
(CI) based on gamma distribution, using age-appropriate 
standard populations. We used the Canadian Census data 
from 2016 to determine the annual intercensal population 
estimates.17 To assess risk of IBD (including CD and UC 
subtypes), we compared incidence in ethnic groups. We 
calculated standardized incidence rate ratio (IRR) adjusted 
for age and sex with 95% CI using Poisson regression. We 
also determined adjusted IRR with 95% CI using negative 
binomial regression model, controlling for sex (female 
reference), immigration category (non-immigrant refer-
ence), income quintile (lowest income quintile as refer-
ence) and RIO rurality index at the time of cohort entry.
To determine the possible protective association of 
immigration status on the risk of IBD, we used multivari-
able models without controlling for immigration status 
(model 1) and controlling for immigration status 
(model 2). Age was categorized into three levels: i) 6 
months to <18 years (paediatric); ii) 18 years to <65 
years (adult); iii) ≥65 years (senior). Interaction between 
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age and the main exposure ethnicity (age*ethnic) was 
included as an independent variable in model 3. If the 
interaction term was significant (p < 0.05), the analysis 
was stratified by age group (model 4). We described nor-
mally distributed continuous variables as means and stan-
dard deviations (SD), and categorical variables were 
expressed as frequency and proportions. Statistical ana-
lyses were performed using Stata version 15 (StataCorp) 
and using SAS version 9.4 (SAS Institute, NC).
Results
Study Participants
Of the 16,230,638 residents of Ontario included in our 
cohort, 982,472 (6.1%) were South Asian and 764,397 
(4.7%) Chinese. Over the follow-up period, 1644 South 
Asians and 444 Chinese developed IBD, and this accounted 
for 3.4% and 0.9% of total incident cases. See Table 1 for the 
descriptive characteristics of the IBD cohort. Males predo-
minated among South Asian and Chinese individuals with 
IBD comprising, respectively, 56% and 58% of these 
cohorts. The IBD South Asian cohort was younger relative 
to the general and Chinese IBD cohorts. Non-immigrant 
South Asian people were diagnosed with IBD at 30.3 
±18.7y, compared to 39.1±18.7y in South Asian immigrants. 
There was no difference observed among immigrants and 
non-immigrants in the Chinese and general IBD cohorts 
(Supplementary Table 2). Less than 5% of the IBD patients 
in the general cohort were immigrants, compared to approxi-
mately 40% of South Asians, and 30% of Chinese IBD 
patients. No person was missing age or sex, and immigration 
status. Two percent of records were missing mean neighbor-
hood income quintile and 0.5% were missing RIO score. 
These residents were removed from the analyses.
Standardized Incidence Rates
Standardized incidence of IBD per 100,000 PYs in the gen-
eral cohort was 24.7 (95% CI 24.4–25.0), compared with 
14.6 (95% CI 13.7–15.5) in South Asians and with 5.4 (95% 
CI 4.8–5.9) in Chinese. The standardized incidence of CD 
per 100,000 PYs among the general cohort (10.6, 95% CI 
10.4–10.7) was significantly higher than in the South Asians 
and Chinese populations (South Asians: 4.28, 95% CI 3.80– 
4.76; Chinese: 1.58, 95% CI 1.26–1.90). The standardized 
Table 1 Descriptive Characteristics of the IBD Population
General Population South Asian Chinese
IBD incident cases 45,508 1644 444
Follow-up person-years 10.0±5.3 10.6±4.88 10.5±5.04
Male 21,959 (48.3%) 912 (55.5%) 259 (58.3%)
Age at diagnosis (y) 39.5±19.3 33.7±18.0 41.1±18.2
Age at diagnosis of immigrant (y) 37.5±15.6 39.1±15.3 41.3±14.7
Age at diagnosis of non-immigrant (y) 39.6±19.4 30.3±18.7 41.0±19.5
Age at diagnosis (y)
<18y 6305(13.9%) 377 (22.9%) 43 (9.7%)
18-<65y 33,831 (74.3%) 1173 (71.4%) 356 (80.2%)
≥65y 5372 (11.8%) 94 (5.7%) 45 (10.1%)
Rural 7525 (16.6%) 64 (3.9%) 14 (3.2%)
Income quintile
1 8526 (19.2%) 519 (31.9%) 98 (22.5%)
2 8839 (19.9%) 415 (25.5%) 95 (21.8%)
3 8954 (20.1%) 320 (19.7%) 97 (22.2%)
4 9183 (20.7%) 240 (14.8%) 87 (20.0%)
5 8947 (20.1%) 131 (8.1%) 59 (13.5%)
Immigrant 1860 (4.1%) 642 (39.1%) 132 (29.7%)
Rurality Index 2008 11.2±17.9 1.7±5.0 2.4±8.2
Notes: Values are presented as N (%), mean ± standard deviation.
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incidence of UC per 100,000 PYs among South Asians 
(9.56, 95% CI 8.83–10.3) and Chinese (3.54, 95% CI 
3.06–4.02) was twice the rate of CD. The incidence rates 
and rate ratios by IBD type are reported in Tables 2 and 3.
Incidence in South Asians Compared with 
the General Population
The risk of IBD in South Asians was lower compared to the 
general population prior to adjusting for immigration status 
(model 1; adjusted IRR (aIRR)0.73, 95% CI 0.69–0.76), but 
the same as the general population after adjusting for immigra-
tion in the model (model 2; aIRR 1.00, 95% CI 0.95–1.05) 
(Table 4). After adjustment for immigration status, only South 
Asian adults had a higher risk of IBD (aIRR 1.10, 95% CI 
1.02–1.18), not children (0.98 95% CI 0.91–1.05) or seniors 
(0.38 95% CI 0.14–1.06) relative to the general population. 
Furthermore, immigration was significantly associated with 
a lower risk of both CD and UC (Table 4 and Supplementary 
Table 3). The incidence of CD in South Asians was lower 
compared to the general population, irrespective of age (aIRR 
0.66, 95% CI 0.60–0.76), whilst the risk of UC was higher in 
South Asian especially among children and adult South Asians 
(aIRR 1.47, 95% CI 1.34–1.61; children aIRR 1.36, 95% CI 
1.24–1.49; adults aIRR 1.30, 95% CI 1.19–1.43). South Asians 
were more likely to develop UC than CD (aIRR 1.51, 95% CI 
1.38–1.66) (Table 5 and Supplementary Table 6). We observed 
a difference in IRR by age, and the incidence rate decreased 
with increasing age among South Asians relative to both the 




Total Population PYs Crude Incidence 
Rate per 100,000 
PYs (95% CI)
Standardized 
Incidence Rate per 
100,000 (PYs) (95% 
CI)
Inflammatory bowel disease
General population 44,325 14,483,769 178,561,105 24.8 (24.6–25.1) 24.7 (24.4–25.0)
South Asian 1610 982,472 9,719,040 16.6 (15.8–17.4) 14.6 (13.7–15.5)
Chinese 439 764,397 8,393,123 5.2 (5.72–4.74) 5.4 (4.8–5.9)
Crohn's Disease
General population 20,425 15,466,241 178,357,430 11.5 (11.3–11.6) 10.6 (10.4–10.7)
South Asian 493 982,472 9,708,882 5.08 (4.65–5.55) 4.28 (3.80–4.76)
Chinese 138 764,397 8,390,392 1.64 (1.37–1.92) 1.58 (1.26–1.90)
Ulcerative Colitis
General population 21,635 15,466,241 178,372,216 12.1 (12.0–12.3) 12.9 (12.7–13.1)
South Asian 1027 982,472 9,713,445 10.6 (9.95–11.2) 9.56 (8.83–10.3)
Chinese 283 764,397 8,391,614 3.37 (3.00–3.79) 3.54 (3.06–4.02)
Table 3 Standardized Incidence Rate Ratio by Ethnicity and IBD Type













South Asian vs 
general
0.69 (0.66–0.73) 0.59 (0.55–0.63) 0.46 (0.42–0.49) 0.41 (0.36–0.45) 0.91 (0.86–0.97) 0.74 (0.69–0.80)
Chinese vs 
general
0.21 (0.19–0.24) 0.22 (0.19–0.24) 0.15 (0.12–0.17) 0.15 (0.12–0.18) 0.28 (0.25–0.32) 0.28 (0.24–0.32)
South Asian vs 
Chinese
3.24 (2.92–3.60) 2.72 (2.40–3.09) 3.10 (2.58–3.74) 2.71 (2.15–3.41) 3.24 (2.84–3.69) 2.70 (2.31–3.15)
Notes: General the comparative reference population cohort. 
Abbreviation: IRR, incidence rate ratio.
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general and Chinese population (Figure 2 and Supplementary 
Figures 1, 2, 5, and 6).
Incidence in Chinese population 
Compared with the General Population
The risk of IBD was much lower in Chinese population, 
irrespective of age, compared to the general population 
(aIRR 0.24, 95% CI 0.20–0.28). This lower risk was 
similar in UC (aIRR 0.28, 95% CI 0.23–0.35) and CD 
(aIRR 0.21 95% CI 0.17–0.26) (Table 4 and 
Supplementary Table 4). Immigration status did not sig-
nificantly change the aIRR in the models (comparing 
model 1 with model 2). The IRR stratified by age and 
sex are demonstrated in Figure 2 (Supplementary 
Figures 3 and 4), with no noticeable difference in IRR 
by age.
Table 4 Incidence Rate Ratio Models of Inflammatory Bowel Disease, Crohn’s Disease and Ulcerative Colitis, Comparing: South Asian 
Compared with General Population, Chinese with General and South Asian with Chinese
Inflammatory Bowel Disease Crohn's Disease Ulcerative Colitis
IRR (95% CI) SE IRR (95% CI) SE IRR (95% CI) SE
South Asian (Ref: General)
Model 1 (-immigration status)† 0.73 (0.69–0.76) 0.02 0.48 (0.44–0.52) 0.02 0.95 (0.89–1.01) 0.03
Model 2 (+ immigration status) 1.0 (0.95–1.05) 0.03 0.70 (0.64–0.77) 0.03 1.25 (1.17–1.33) 0.04
Model 3 (*agegp) 1.03 (0.96–1.10) 0.04 0.66 (0.60–0.76) 0.04 1.47 (1.34–1.61) 0.07
Model 4a (<18y) 0.98 (0.91–1.05) 0.04 0.66 (0.58–0.74) 0.04 1.36 (1.24–1.49) 0.07
Model 4b (18-<65y) 1.10 (1.02–1.18) 0.04 0.77 (0.67–0.89) 0.06 1.30 (1.19–1.43) 0.06
Model 4c (>65y) 0.38 (0.14–1.06) 0.20 0.19 (0.02–1.64) 0.21 0.61 (0.18–2.02) 0.37
Chinese (Ref: General)
Model 1 (-immigration status)† 0.22 (0.20–0.24) 0.01 0.15 (0.13–1.18) 0.01 0.28 (0.25–0.32) 0.02
Model 2 (+immigration status) 0.26 (0.24–0.29) 0.01 0.19 (0.16–0.23) 0.02 0.33 (0.29–0.37) 0.02
Model 3 (*agegp) 0.24 (0.20–0.28) 0.02 0.21 (0.17–0.26) 0.02 0.28 (0.23–0.35) 0.03
Model 4a (<18y) 0.23 (0.20–0.27) 0.02 0.20 (0.16–0.26) 0.02 0.27 (0.21–0.33) 0.03
Model 4b (18-<65y) 0.30 (0.26–0.33) 0.02 0.18 (0.14–0.23) 0.02 0.38 (0.33–0.44) 0.03
Model 4c (>65y) 0.22 (0.09–0.52) 0.10 0.19 (0.04–0.88) 0.15 0.27 (0.09–0.81) 0.15
South Asian (Ref: Chinese)
Model 1(-immigration status)† 3.37 (3.03–3.75) 0.18 3.15 (2.61–3.81) 0.30 3.40 (2.98–3.89) 0.23
Model 2 (+immigration status) 3.73 (3.35–4.15) 0.20 3.52 (2.90–4.24) 0.34 3.76 (3.29–4.30) 0.26
Model 3 (*agegp) 4.29 (3.62–5.08) 0.37 3.26 (2.45–4.09) 0.41 5.19 (4.01–6.57) 0.63
Model 4a (<18y) 4.25 (3.58–5.04) 0.37 3.19 (2.46–4.13) 0.42 5.13 (4.04–6.51) 0.62
Model 4b (18-<65y) 3.54 (3.07–4.08) 0.26 3.76 (2.82–5.02) 0.55 3.38 (2.85–4.01) 0.29
Model 4c (>65y) 2.24 (0.61–8.19) 1.48 1.35 (0.12–15.0) 1.66 3.63 (0.51–25.9) 3.64
Notes: All models adjusted for covariates: immigration status †exclusion of immigration status from model 1), male (female as reference), neighbourhood income quintile 
(lowest income quintile as reference) and RIO2008, *Agegp interaction term. 
Abbreviations: CI, confidence intervals; IRR, incidence rate; SE, standard error.
Table 5 Incidence Rate Ratio Models of Ulcerative Colitis Relative to Crohn’s Disease
South Asian General (REF) Chinese General (REF) South Asian Chinese (REF)
IRR (95% CI) SE IRR (95% CI) SE IRR (95% CI) SE
Model 1 (-immigration status) 1.25 (1.17–1.33) 0.04 1.24 (1.09–1.39) 0.07 1.00 (0.88–1.15) 0.07
Model 2 (+immigration status) 1.19 (1.12–1.28) 0.04 1.20 (1.06–1.35) 0.07 0.99 (0.87–1.14) 0.07
Model 3 (*agegp) 1.51 (1.38–1.66) 0.07 1.09 (0.87–1.36) 0.12 1.36 (1.08–1.73) 0.16
Notes: All models adjusted for covariates: immigration status (†exclusion of immigration status from model 1), male (female as reference), neighbourhood income quintile 
(lowest income quintile as reference) and RIO2008. *Agegp interaction term. 
Abbreviations: CI, confidence intervals; IRR, incidence rate; SE, standard error; REF, reference group.
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Incidence in South Asian Population 
Compared with the Chinese Population
The risk of IBD among South Asian children and adults was 
approximately four times higher than the Chinese popula-
tion, irrespective of IBD type (Table 4 and Supplementary 
Table 5). South Asians had a greater risk of ulcerative colitis 
(vs CD) compared to Chinese population (IRR1.36, 95% CI 
1.08–1.73) (Table 5), and the risk of IBD (CD/UC) among 
South Asian relative to Chinese decreased with age 
(Figure 2 and Supplementary Figures 5 and 6).
Discussion
In this population-based study, the risk of developing IBD 
among South Asian people was comparable to the general 
population after adjusting for immigration status. This was 
not the case for Chinese residents, who had a significantly 
lower risk of IBD in both immigrants and non-immigrants. 
Notably, after adjustment for immigration status and other 
confounders, the risk of UC in South Asians was 1.5-fold 
higher than the general population. There was a male pre-
dominance in both the Chinese and South Asian IBD cohorts 
compared to the general population cohort. We also observed 
a distinct age-risk relationship in South Asians only, with 
higher relative incidence in younger people. Furthermore, 
South Asian and Chinese people were more likely to develop 
UC relative to CD compared to the general population. Our 
study supports the hypothesis that the likelihood of IBD, 
specifically UC, among the South Asian population is greater 
than in the Chinese population, and like the high incidence 
rates of IBD described in the general Canadian population.
The landscape of IBD is evolving; in the Western world, 
incidence is stabilizing and regions transitioning into 
a compounding prevalence stage, whilst newly industrialised 
countries entering acceleration in incidence stage, associated 
with rising incidence and low prevalence.2,18 This is particu-
larly evident in South Asia, with countries such as India 
approaching the incidence of IBD comparable to the West.2 
The present study further supports the notion that the risk of 
IBD increases in certain migrant groups from countries with 
lower IBD prevalence once they arrive to higher prevalence 
countries such as Canada, USA and the United 
Kingdom.6,19–21 The predominance of UC observed in both 
South Asian and Chinese IBD populations is consistent with 
other population-based studies from the Asia-Pacific 
region.22 The comparatively lower CD incidence rates may 
be attributed to the lack of a genotypic association. CD- 
associated polymorphisms in the NOD2/CARD15 gene are 
strongly associated with ileal CD,23 but the higher prevalence 
of these common risk alleles of European origin has not been 
widely observed in South Asians24 and Chinese patients.25 
Likewise, population studies in the United Kingdom19,20 
have observed a higher risk of UC among adult South 
Asians. In addition, using self-reported ethnicity in 
a prospective Canadian pediatric inception cohort study, we 
recently observed a predominance of UC in South Asian 
children and adolescents with IBD.26 We previously demon-
strated that earlier age of immigration was associated with an 
increased risk of IBD, with risk increasing by 14% for every 
younger decade of life at immigration.6 Similarly, in our 
cohort, South Asians born in Canada with IBD presented at 
an earlier age relative to South Asian immigrants and the 
Chinese and general populations. These findings support that 
earlier exposure to the Canadian environment increases the 
risk of IBD and moreover UC, in this population.
Line of best fitted visually   
B Chinese vs GeneralA South Asian vs General C South Asian vs Chinese
Figure 2 Inflammatory bowel disease unadjusted incidence rate ratio stratified by age and sex; [A] South Asian compared with general population; [B] Chinese compared 
with “general” population; [C] South Asian compared with Chinese population.
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It has been speculated that early exposure to environ-
mental risk factors modifies the risk of developing IBD in 
genetically susceptible individuals.27,28 Notably, the emer-
gence of IBD in Asian and Asian-Pacific countries asso-
ciated with Westernisation signifies the important role of 
environmental factors.2,22 A recent meta-analysis of obser-
vational studies identified nine risk (smoking, urban living, 
vitamin D deficiency) and seven protective environmental 
factors (breastfeeding, tea, physical activity), with moder-
ate to high epidemiologic evidence of association.27 
However, evidence of association does not equate to caus-
ality and factors such as serum vitamin levels and micro- 
organisms may be a consequence of reverse causation. The 
degree to which, and pathophysiologic mechanism by 
which, these environmental exposures contribute to risk 
of developing IBD remains to be elucidated. The relative 
contribution of environmental risk factors may vary 
according to the population studied. In our study, the risk 
of IBD among the Chinese population remained low even 
after adjusting for immigration, suggesting that exposure 
to the Canadian environment, even in people born in 
Canada, may not trigger IBD in people of Chinese origin. 
Protective genetic or microbiome factors may mitigate 
such environmental effects. These findings highlight the 
heterogeneity of the disease and the complex interplay of 
environmental, microbial, immunological and genetic fac-
tors, and future research should further assess the interplay 
of these factors among various ethno-cultural groups.
The strengths of this study include its large sample size 
and population-based study design. Linkage of multiple 
health administrative databases allowed us to calculate the 
incidence of IBD within ethnic groups in Ontario, and to 
adjust for known confounders. The use of health adminis-
trative data presents some limitations, including risk of 
misclassification bias, which could result from miscategor-
ising people as having or not having IBD. However, we 
used validated algorithms in our study to identify patients 
with IBD, differentiate incident from prevalent cases, and 
classify IBD patients as having CD or UC.12,13 The IBD 
algorithms were not specifically validated in immigrants 
and we may have differentially misclassified people in 
these groups as having or not having IBD based on their 
health services utilisation patterns. However, we pre-
viously reported that health services utilisation was not 
different among immigrants with IBD compared to non- 
immigrants, reducing the risk of differential 
misclassification.29
Another limitation of this study is the assignment of 
South Asian ethnicity based on a surname-based algo-
rithm, which was an excellent PPV but a sensitivity of 
50.4%.7 The lower sensitivity was likely due to the exclu-
sion of South Asian people with Muslim or European 
surnames, as to avoid misclassification. To overcome this 
weakness, we linked immigration and birth data to assign 
ethnicity. Immigrants from South Asia or China/ 
Hong Kong were classified as being of South Asian and 
Chinese ethnicity, respectively, even when the surname 
algorithm did not classify them as such. The children of 
immigrant mothers from those regions were classified with 
the same approach. However, immigration data were only 
available from 1985, and include only immigrants whose 
first place of landing was Ontario. Therefore, there is still 
the risk of misclassification. In our study, South Asians 
comprised 6.1% and Chinese 4.7% of the entire Ontario 
population, which was analogous to the 2006 and 2016 
Canadian census (South Asian 6.6% and 8.7%, Chinese 
4.7% and 5.7%, respectively).4,30 Finally, Ontario health 
administrative data does not link records of fathers to their 
children, and therefore we were uncertain of the fathers’ 
immigration status. However, the overall rate of intermar-
riage among minority populations in Canada is low 
(13.0% in South Asians, 19.4% in Chinese).31
In conclusion, we found that the incidence of IBD 
among South Asians living in Canada was comparable to 
the high incidence seen in other Canadians, and signifi-
cantly higher than incidence rates seen in first-generation 
immigrants to Canada. Rates in South Asians were much 
higher than in the Chinese population, even when they 
were born in Canada. The strong protective effect of 
immigration to Canada implies that environmental factors 
to which non-immigrant Canadians of South Asian descent 
are exposed increase the risk of this immune mediated 
inflammatory disease. Further research is warranted to 
understand the pathophysiological reasons for these epide-
miological findings, and to understand the health-care 
needs of the growing numbers of South Asian people 
with IBD.
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